We don’t know when (exactly) Lilly will announce the FDA’s baricitinib decision, but watch out for the looming pricing squabble
Sometime in the next few days, the FDA will be right on the PDUFA decision deadline for baricitinib. We just don’t know which day …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
